Angélique Bruyer

Comprehensive characterization of the mutational landscape in multiple myeloma cell lines reveals potential drivers and pathways associated with tumor progression and drug resistance

Veronika Vikova, Michel Jourdan, Nicolas Robert et al. · Theranostics · 2019 · 79 citations · Full text

RECQ1 helicase is involved in replication stress survival and drug resistance in multiple myeloma

Elena Viziteu, Bernard Klein, Jihane Basbous et al. · Leukemia · 2017 · 71 citations · Full text

Replication Stress Survival, Chromatin, Genome Instability +14

Kinome expression profiling to target new therapeutic avenues in multiple myeloma

Hugues de Boussac, Angélique Bruyer, Michel Jourdan et al. · Haematologica · 2019 · 46 citations · Full text

Hematological Malignancy, Tumor Biology, New Therapeutic Avenues +14

Global miRNA expression analysis identifies novel key regulators of plasma cell differentiation and malignant plasma cell

Alboukadel Kassambara, Michel Jourdan, Angélique Bruyer et al. · Nucleic Acids Research · 2017 · 36 citations · Full text

DNMTi/HDACi combined epigenetic targeted treatment induces reprogramming of myeloma cells in the direction of normal plasma cells

Angélique Bruyer, Ken Maes, Laurie Herviou et al. · British Journal of Cancer · 2018 · 36 citations · Full text